Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.
Inmedix has raised $720K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in November 2024.
Inmedix's investors include Keiretsu Capital, Keiretsu Forum Northwest, K4 Forum Mumbai Network.
Inmedix is headquartered in Seattle, United States.
Inmedix brings cloud-based clinical diagnostics and immuno-autonomics to medicine to improve outcomes in autoimmune diseases and beyond.
Inmedix is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Inmedix — Funding & Investors." VCBacked, November 1, 2024, https://www.vcbacked.co/company/inmedix. Accessed September 30, 2026.
VCBacked. (2024). Inmedix — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/inmedix
{{cite web |title=Inmedix — Funding & Investors |url=https://www.vcbacked.co/company/inmedix |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated